Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
Conditions: Esophageal Cancer - Lung Cancer - Malignant Mesothelioma - Metastatic Cancer
2 Locations available
- Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
Conditions: Renal Cell Cancer
1 Location available
- Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Conditions: Metastatic Breast Cancer - Advanced Breast Cancer - Gastrointestinal Stromal Tumor - Hepatocellular Carcinoma - Metastasizing Breast Cancer (F) - Metastatic Castration-Resistant Prostrate Cancer - Metastatic Renal Cell Cancer - Non Small Cell Lung Cancer
2 Locations available
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Pemetrexed in Treating Patients With Advanced Non-Small Cell Lung Cancer, Breast Cancer, or
Conditions: Breast Cancer - Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
3 Locations available
- A Phase I Study to Assess the Safety and Distribution of VB-111 in Patients With Advanced Metastatic Cancer
Conditions: Advanced and/or Metastatic Solid Organ Cancer
3 Locations available
- Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer
1 Location available
- Multipeptide Vaccine for Advanced Breast Cancer
Conditions: Breast Neoplasm - Breast Cancer - Cancer of the Breast - Carcinoma, Ductal
1 Location available
- Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Recta
Conditions: Colorectal Cancer
1 Location available
- Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
Conditions: Liver Cancer
1 Location available
- Vaccine Therapy and GM-CSF in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Conditions: Pancreatic Cancer
1 Location available
- Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
- HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
Conditions: Advanced Breast Cancer
1 Location available
- Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Kidney Cancer
3 Locations available
- A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Conditions: Advanced Malignancy - Advanced Solid Tumors - Cancer - Solid Tumors - Tumors
2 Locations available
- Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer
5 Locations available
- Testosterone for Treating Cachexia in Patients With Advanced or Recurrent Cervical Cancer
Conditions: Cachexia - Cervical Cancer
1 Location available
- Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumor Cancers - Medulloblastoma - Basal Cell Carcinoma
2 Locations available
- Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
Conditions: Head and Neck Cancer - Cancer of Nasopharynx
1 Location available
- Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melan
Conditions: Kidney Cancer - Melanoma (Skin)
1 Location available
- MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer
Conditions: Anxiety Disorder - Cancer
1 Location available
- A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers
Conditions: Advanced Solid Cancers
1 Location available
- AFP464 in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Kidney Cancer - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners
Conditions: Prostate Cancer - Psychosocial Effects of Cancer and Its Treatment - Sexual Dysfunction and Infertility - Sexuality and Reproductive Issues
2 Locations available
- M.D. Anderson Symptom Inventory (MDASI) Validation Study in Cancer Patients
Conditions: Advanced Cancer
1 Location available
- Valproic Acid and Bevacizumab in Patients With Advanced Cancer
Conditions: Advanced Cancer
1 Location available
- Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer
Conditions: Prostate Cancer
1 Location available
- Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
5 Locations available
- A Study Of Oral PF-02341066, A c-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer
Conditions: Systemic Anaplastic Large-Cell Lymphoma - Neoplasms - Anaplastic Lymphoma Kinase, Human - NSCLC
9 Locations available
- Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer - Stage IIIB Non-small Cell Lung Cancer - Stage IV Non-small Cell Lung Cancer
4 Locations available
- Pazopanib in Treating Patients With Advanced Thyroid Cancer
Conditions: Head and Neck Cancer
11 Locations available
- Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Conditions: Endometrial Cancer
1 Location available
- Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Conditions: Hereditary Clear Cell Renal Cell Carcinoma - Kidney Cancer
1 Location available
- A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Conditions: Advanced or Metastatic Solid Tumors - Advanced or Metastatic Breast Cancer
1 Location available
- Intrapleural Catheter Daily Versus Three Times a Week Drainage
Conditions: Advanced Cancer - Pleural Effusion
1 Location available
- Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma
Conditions: Risk for Colorectal Cancer
1 Location available
- Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC
Conditions: Non Small Cell Lung Cancer
3 Locations available
- Bevacizumab and Ixabepilone in Treating Patients With Advanced Kidney Cancer
Conditions: Kidney Cancer
1 Location available
- Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma
Conditions: Advanced Cancer, Various, NOS
6 Locations available
- Dose-escalation Study of Oral CX-4945
Conditions: Advanced Solid Tumors - Breast Cancer - Inflammatory Breast Cancer - Castleman's Disease - Multiple Myeloma
4 Locations available
- Study of Erlotinib in Combination With Dasatinib
Conditions: Advanced Cancer
1 Location available
- Study of Erlotinib in Combination With Bortezomib
Conditions: Advanced Cancer
1 Location available
- An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status
Conditions: Advanced Cancers
1 Location available
- A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors - Cancer - Solid Cancers
4 Locations available
- PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
Conditions: Cancer - Colon Cancer - Colorectal Cancer - Fever - Locally Advanced - Metastatic Colorectal Cancer - Neutropenia - Rectal Cancer
47 Locations available
- Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
Conditions: Cancer of the Cervix
1 Location available
- Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- PXD101 and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Bladder Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
24 Locations available
- Bevacizumab in Multiple Phase I Combinations
Conditions: Advanced Cancer
1 Location available
- Erlotinib and Stereotactic Body Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Non-Small Call Lung Cancer
Conditions: Lung Cancer
2 Locations available
- Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Biliary Cancer - Pancreatic Cancer
1 Location available
- MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
1 Location available
- Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Conditions: Rectal Cancer
4 Locations available
- Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer - Prostate Cancer
1 Location available
- A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
Conditions: Hedgehog Pathway - Smoothened - Basal Cell Carcinoma (BCC) - Basal Cell Nevoid Syndrome (BCNS)
2 Locations available
- Cognitive and Behavioral Therapy or Standard Care in Patients With Advanced Gastrointestinal Cancer or Lung Cancer
Conditions: Anxiety Disorder - Colorectal Cancer - Depression - Esophageal Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Psychosocial Effects of Cancer and Its Treatment
1 Location available
- A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
Conditions: Metastatic Castration-resistant Prostrate Cancer (mCRPC) - Renal Cell Carcinoma (RCC) - Metastatic Melanoma (MEL) - Non-small Cell Lung Cancer (NSCLC)
10 Locations available
- Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
Conditions: Locally Advanced (Unresectable) Pancreatic Cancer - Metastatic Pancreatic Cancer
3 Locations available
- FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
165 Locations available
- Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
Conditions: Head and Neck Cancer
2 Locations available
- Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Sirolimus and Cetuximab in Advanced Malignancies
Conditions: Advanced Cancer
1 Location available
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
496 Locations available
- Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer
Conditions: Carcinoma, Non Small Cell Lung
1 Location available
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Conditions: Advanced Cancers
1 Location available
- Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Conditions: Kidney Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
Conditions: Squamous Cell Carcinoma of the Head and Neck - Basaloid Squamous Cell Carcinoma - Undifferentiated Carcinoma - Adenosquamous Cell Carcinoma
1 Location available
- RECONSTRUCTIVE SURGERY For Head And Neck Cancer Patients
Conditions: Advanced Stage Head and Neck Cancer
1 Location available
- Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
Conditions: Metastatic Liver Cancer
1 Location available
- Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer
1 Location available
- Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Conditions: Prostate Cancer
1 Location available
- Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Conditions: Cervical Cancer
13 Locations available
- Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer
Conditions: Cancer
1 Location available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- Study of Temsirolimus, Topotecan, and Bortezomib
Conditions: Advanced Cancer
1 Location available
- Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers
Conditions: Advanced Cancer
3 Locations available
- Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Conditions: Cancer
1 Location available
- Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Conditions: Male Breast Cancer - Recurrent Breast Cancer - Skin Metastases - Stage IV Breast Cancer
1 Location available
- Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma - Renal Cancer
2 Locations available
- Initiative for Molecular Profiling in Advanced Cancer Therapy (IMPACT) Trial, An Umbrella Protocol
Conditions: Advanced Cancers
1 Location available
- Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer
Conditions: Head and Neck Cancer
1 Location available
- Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (
Conditions: Non-Small Cell Lung Cancer
4 Locations available
- Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
Conditions: Non Small Cell Lung Cancer - Small Cell Lung Cancer - Thymoma - Thymus Neoplasms
1 Location available
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Graft-Versus-Host Disease - Engraftment Syndrome
2 Locations available
- Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma
Conditions: Biliary Cancer - Cholangiocarcinoma
1 Location available
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma - Biliary Tract Cancer - Gallbladder Cancer
1 Location available
- Treatment of Patients With Advanced Renal Cancer With a Radio-labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma - Kidney Neoplasm - Renal Cancer - Kidney Cancer
1 Location available
- Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
Conditions: Kidney Cancer
5 Locations available
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
127 Locations available
- Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer - Venous Thromboembolism
1 Location available
- Psychophysical Studies of Cancer Therapy-Induced Pain
Conditions: Advanced Cancer - Pain
1 Location available
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer
1 Location available
- Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer
1 Location available
- Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm - Carcinoma Non-small Cell Lung Cancer Stage IIIA - Carcinoma Non-small Cell Lung Cancer Stage IIIB - Carcinoma Non-small Cell Lung Cancer Stage IV
50 Locations available
- Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
Conditions: Advanced Cancer
1 Location available
- Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Can
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer
21 Locations available
- A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffe
Conditions: Solid Cancers
3 Locations available
- Caregiver Assessments of the Quality of Home Hospice Care
Conditions: Advanced Cancer
1 Location available
- Plasma and Urine Biomarkers in Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy
Conditions: Prostate Cancer
1 Location available
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
13 Locations available
- An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gen
Conditions: Carcinoma, Non-Small-Cell Lung
4 Locations available
- Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab
Conditions: Advanced Cancers
1 Location available
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
19 Locations available
- Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
24 Locations available
- A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Carcinoma (NSCLC)
Conditions: Non-Small Cell Lung Cancer
2 Locations available
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer o
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
1 Location available
- Advanced Care Planning Using the Five Wishes Document in Young Patients With Metastatic, Recurrent, or Progressive Cancer or HIV Disease
Conditions: Psychosocial Effects of Cancer and Its Treatment - Transitional Care Planning - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
2 Locations available
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma
Conditions: Bladder Cancer
1 Location available
- Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers
Conditions: Advanced Cancers
1 Location available
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Hereditary Breast and Ovarian Cancer Syndrome - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2
Conditions: Breast Cancer - Metastatic Cancer
1 Location available
- Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer
Conditions: Prostate Cancer
2 Locations available
- A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer
Conditions: Carcinoma, Squamous Cell
1 Location available
- Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
1 Location available
- Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Conditions: Kidney Cancer
2 Locations available
- Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
Conditions: Advanced Cancers
1 Location available
- A Trial In Patients With Advanced Cancer And Leukemia
Conditions: Neoplasms by Histologic Type - Leukemia, Lymphoid - Leukemia, T-Cell - Solid Tumors
6 Locations available
- Clinical Response to Chemotherapy With Fluoro-L-Thymidine With Positron Emission Tomography (FLT-PET)
Conditions: Advanced Cancers
1 Location available
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
Conditions: Small Cell Lung Carcinoma - Malignant Epithelial Neoplasms
1 Location available
- Dyspnea in Advanced Cancer Patients
Conditions: Advanced Cancers
1 Location available
- Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Conditions: Colorectal Cancer
3 Locations available
- A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Conditions: Triple Negative Breast Cancer
1 Location available
- Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Gastric Cancer
17 Locations available
- A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
5 Locations available
- Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer
Conditions: Stage III Prostate Cancer
1 Location available
- OSI-906 and Irinotecan in Patients With Advanced Cancer
Conditions: Colorectal Cancer
1 Location available
- Immunotoxin Therapy, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Lung Cancer
1 Location available
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
297 Locations available
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Neuroblastoma - Sarcoma
1 Location available
- Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Conditions: Pancreatic Neoplasms
1 Location available
- Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
1 Location available
- Olanzapine in Patients With Advanced Cancer and Weight Loss
Conditions: Advanced Cancer - Weight Loss
1 Location available
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis
Conditions: Peritoneal Cancer
1 Location available
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer
Conditions: Cancer
1 Location available
- Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Lung Cancer
3 Locations available
- Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer
Conditions: Advanced Metastatic Carcinoma
1 Location available
- Improving Clinician Communication Skills (ICCS)
Conditions: Advanced Cancer - Chronic Obstructive Pulmonary Disease (COPD) - Restrictive Lung Disease - Congestive Heart Failure - End Stage Liver Disease
4 Locations available
- Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Conditions: Pain/Cancer - Pain, Intractable
1 Location available
- A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
Conditions: Cancer - Oncology - Tumors - Advanced Malignancy - Advanced Solid Tumors - Oncology Patients
3 Locations available
- Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
1 Location available
- Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
Conditions: Liver Cancer
7 Locations available
- Erlotinib in Combination With Cetuximab
Conditions: Advanced Cancers
1 Location available
- Study of Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-Small Cell Lung Cancer
65 Locations available
- Psilocybin Advanced Cancer Anxiety Study
Conditions: Cancer
1 Location available
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- A Phase 1 Study in Patients With Advanced Cancer
Conditions: Advanced Cancer - Non Small Cell Lung Cancer - Colorectal Cancer - Ovarian Cancer
2 Locations available
- Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
Conditions: Breast Cancer - Neoplasm Metastasis
1 Location available
- Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Conditions: Kidney Cancer
55 Locations available
- Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
Conditions: Head and Neck Cancer
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
381 Locations available
- Diffuse Optical Spectroscopy Imaging in Monitoring and Predicting Response in Patients With Locally Advanced Breast Cancer Undergoing Chemotherapy Bef
Conditions: Breast Cancer
2 Locations available
- A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Advanced Prostate Cancer
Conditions: Prostate Neoplasms
3 Locations available
- Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
1 Location available
- Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Conditions: Cancer
2 Locations available
- Measuring Sleep Disturbance Among Cancer Patients
Conditions: Advanced Cancer
2 Locations available
- Study of Combined Fulvestrant and RAD001 in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Conditions: Breast Cancer
1 Location available
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer, - Advanced Solid Tumors, - Cowden Syndrome
8 Locations available
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
181 Locations available
- Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy
Conditions: Advanced Cancer - Bone Metastases
1 Location available
- Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
1 Location available
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
11 Locations available
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer - Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
157 Locations available
- A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver
Conditions: Hepatocellular Carcinoma
7 Locations available
- Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
Conditions: Advanced Non-small Cell Lung Cancer - Postmenopausal Women
1 Location available
- A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer
Conditions: Advanced Malignancies, Non-small Cell Lung Cancer
2 Locations available
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
37 Locations available
- A Dose Escalation Study of an Antibody in Patients With Advanced Cancers
Conditions: Advanced Cancers
2 Locations available
- Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Carcinoma
4 Locations available
- Trial of Bi-shRNA-furin and Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented Autologous Tumor Cell Vaccine for Advanced Cancer
Conditions: Solid Tumors
1 Location available
- Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer
Conditions: Liver Cancer
1 Location available
- Sirolimus and Vorinostat in Advanced Cancer
Conditions: Advanced Cancer
1 Location available
- A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regime
Conditions: Advanced Solid Tumors - Adenocarcinoma of the Prostate
1 Location available
- A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
Conditions: Head and Neck Cancer
1 Location available
- Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies
Conditions: Advanced Cancer
1 Location available
- STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer
Conditions: Esophagogastric Cancer
2 Locations available
- MLN8237 in Adults With Nonhematological Malignancies, Followed by MLN8237 in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
Conditions: Advanced Nonhematological Malignancies - Non-Small Cell Lung Cancer - Small Cell Lung Cancer - Metastatic Breast Cancer - Head and Neck Squamous Cell Carcinoma - Gastroesophageal Adenocarcinoma
3 Locations available
- Characterization of Circulating Tumor Cells (CTCs) to Direct Pre-Operative and Systemic Therapy in Patients With Locally Advanced or Metastatic Stage
Conditions: Locally Advanced Breast Cancer - Metastatic (Stage IV) Breast Cancer - Stage III-IV Breast Cancer or Inflammatory
1 Location available
- Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Cancer - Solid Tumors - Lymphoma - Malignancy
3 Locations available
- Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After
Conditions: Colorectal Cancer
238 Locations available
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
363 Locations available
- Trial Of Cisplatin And KML-001 In Advanced Non-Small Cell Lung Cancer and Other Platinum Responsive Malignancies
Conditions: Advanced Non-Small Cell Lung Cancer - Platinum Responsive Malignancies
1 Location available
- A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary
Conditions: HLRCC - Metastatic Papillary RCC
1 Location available
- FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib
Conditions: Advanced Cancer
1 Location available
- Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
Conditions: Pancreatic Cancer
1 Location available
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Conditions: Bladder Cancer - Renal Pelvis Cancer - Ureter Cancer
1 Location available
- CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
Conditions: Gastrointestinal Cancer
1 Location available
- Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer
Conditions: NSCLC (Advanced Non-small Cell Lung Cancer)
14 Locations available
- Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of th
Conditions: Non Small Cell Lung Cancer - NSCLC
18 Locations available
- AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breas
Conditions: Breast Cancer
9 Locations available
- Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Conditions: Advanced Solid Tumors - Metastatic Colorectal Cancer
1 Location available
- MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy
Conditions: Liver Cancer
23 Locations available
- Combination With Gemcitabine in Advanced Pancreatic Cancer
Conditions: Pancreatic Neoplasms
1 Location available
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
Conditions: Hepatocellular Carcinoma - Liver Cancer
1 Location available
- Akt Inhibitor MK-2206 in Patients With Advanced Breast Cancer Who Have Tumors With a PIK3CA Mutation and/or PTEN Loss
Conditions: Breast Cancer
1 Location available
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Bladder Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter
5 Locations available
- Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Colorectal Cancer - Head and Neck Cancer - Neoplasm Metastasis
3 Locations available
- Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Conditions: Non-small Cell Lung Cancer
3 Locations available
- A Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
4 Locations available
- Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Conditions: Head and Neck Cancer
123 Locations available
- Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Conditions: Cancer - Advanced Solid Malignancies
3 Locations available
- HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
Conditions: Liver Cancer - Advanced Cancer
1 Location available
- Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies
Conditions: Lung Cancer
1 Location available
- Physician Perceptions About Parenteral Hydration in Latin America and Spain
Conditions: Dehydration - Advanced Cancers
1 Location available
- Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Cancer
Conditions: Endometrial Cancer - Endometrial Neoplasms
9 Locations available
- Study of Lung Chemotherapy in the Treatment of Advanced Lung Cancer and Metastatic Sarcoma
Conditions: Lung Cancer - Sarcoma
1 Location available
- Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
Conditions: Non-Small-Cell Lung Cancer
11 Locations available
- A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer
Conditions: Esophageal Cancer
1 Location available
- Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Conditions: Prostate Cancer
46 Locations available
- Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Conditions: Locally Advanced Non-small Cell Lung Cancer
3 Locations available
- A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Me
Conditions: Solid Cancers
3 Locations available
- Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
8 Locations available
- RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer
4 Locations available
- Bendamustine and Bevacizumab for Advanced Cancers
Conditions: Advanced Cancer
1 Location available
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Ovarian Cancer - Prostate Cancer
1 Location available
- Tolvaptan in Hyponatremic Cancer Patients
Conditions: Advanced Cancers
1 Location available
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low- or Intermediate-Grade Neuroendocrine Cancer
Conditions: Extra-Adrenal Paraganglioma - Gastrointestinal Carcinoid Tumor - Head and Neck Cancer - Islet Cell Tumor - Lung Cancer - Neuroendocrine Carcinoma of the Skin - Pheochromocytoma
1 Location available
- Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer - Lung Cancer - NSCLC
1 Location available
- A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Sm
Conditions: Small Cell Lung Cancer and Other Solid Tumors
2 Locations available
- A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
Conditions: Pain
18 Locations available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- BAY80-6946 Open Label, Phase I Study in Patients With Advanced Cancer
Conditions: Neoplasms
3 Locations available
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors
Conditions: Non-Small Cell Lung Cancer, Solid Cancers
2 Locations available
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duoden
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Pancreatic Cancer - Periampullary Adenocarcinoma - Small Intestine Cancer
2 Locations available
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian S
Conditions: Ovarian Cancer
47 Locations available
- Docetaxel and Sirolimus in Patients With Advanced Malignancies
Conditions: Advanced Cancer
1 Location available
- Dose Escalation Study of INK128 in Subjects With Advanced Cancer
Conditions: Advanced Solid Malignancies
3 Locations available
- Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
Conditions: Advanced Non-squamous Non-Small Cell Lung Cancer
1 Location available
- Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
Conditions: Squamous Cell Carcinoma - Laryngeal Cancer
1 Location available
- MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer
Conditions: HER2 Amplified Breast Cancer - Metastatic or Advanced Breast Cancer
3 Locations available
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
3 Locations available
- A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Pharmacokinetics of AGS-16M8F
3 Locations available
- A Study of IMC-RON8 in Advanced Solid Tumors
Conditions: Cancer
2 Locations available
- Randomized Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Conditions: Head and Neck Cancer
1 Location available
- Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Conditions: Neoplasm - Cancer - Tumors
4 Locations available
- Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cancer
Conditions: Rectal Cancer
1 Location available
- GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco
20 Locations available
- A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + MK-8669 Combination Therapies in Participants With Advanced Cancer (MK-0646
Conditions: Neoplasms Malignant
6 Locations available
- Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
Conditions: Colorectal Cancer - Head and Neck Cancer
1 Location available
- MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
135 Locations available
|